Breen took over as DuPont CEO following the abrupt resignation in October of Ellen Kullman , who just a few months earlier fended off a proxy challenge by Trian Fund Management , a hedge fund led by activist investor Nelson Peltz . Peltz has called for DuPont ' s agriculture , nutrition and health and industrial biosciences units to be combined into a single growth company , separate from the more cyclical businesses of performance materials , safety and protection , and electronics and communication .
